Cannabis Use, Neurobiology, Psychology, and Treatment
eBook - ePub

Cannabis Use, Neurobiology, Psychology, and Treatment

  1. 670 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Cannabis Use, Neurobiology, Psychology, and Treatment

About this book

Cannabis Use, Neurobiology, Psychology, and Treatment offers readers a comprehensive reference on neurological changes, both transient and long-term, and other factors surrounding the use of these compounds and extracts. With coverage of both natural and synthetic cannabinoids, this broad coverage allows readers to learn about both adverse and non-adverse effects, including reactivity to pain, changes in behavior, and neuroactivity. This volume provides a platform for research on the effects of these compounds in brain function and neurological dysfunction. Extracts from the Cannabis sativa plant contain scores of psychoactive compounds in addition to the principal agent tetrahydrocannabinol, many of which are neuroactive. - Summarizes cannabis and cannabinoid research in relation to neurological function - Contains chapter abstracts, key facts, a dictionary and a summary - Covers the neuroactivity of multiple Cannabis compounds beyond tetrahydrocannabinol - Includes conditions like depression, anxiety, Parkinson's, psychosis, and epilepsy - Discusses brain structure and brain development, including functional connectivity

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Cannabis Use, Neurobiology, Psychology, and Treatment by Colin R Martin,Vinood B. Patel,Victor R Preedy,Colin R. Martin in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Physiology. We have over one million books available in our catalogue for you to explore.

Information

Table of contents

  1. Cover
  2. Front Matter
  3. Table of Contents
  4. Copyright
  5. Dedication
  6. Contributors
  7. Preface
  8. List of Illustrations
  9. List of Tables
  10. Chapter 1 : Metabolomics of the cannabis plant
  11. Chapter 2 : Cannabis sativa roots: Chemical and pharmacological profile
  12. Chapter 3 : Cannabis-related compounds in beverages and food
  13. Chapter 4 : The impact of prenatal cannabis exposure: An overview
  14. Chapter 5 : Cannabinoid genotoxicity and congenital anomalies: A convergent synthesis of European and USA data sets
  15. Chapter 6 : Cannabis genotoxicity and cancer incidence: Highly concordant synthesis of European and USA datasets
  16. Chapter 7 : Cannabis, cognitive impairment and car crash risk
  17. Chapter 8 : Recreational cannabis use: French perspective of adverse effects
  18. Chapter 9 : Acute and chronic impact of cannabis on human cognition
  19. Chapter 10 : Polydrug users, use of cannabinoids and abuse potential: A focus on cannabidiol (CBD)
  20. Chapter 11 : Cannabis stigmas: A narrative of features
  21. Chapter 12 : Alterations of THC and CBD ratios and impact on cognition
  22. Chapter 13 : When cannabis is used for medicinal purposes: A focus on back pain
  23. Chapter 14 : Cannabis, cannabinoids, and receptor responses
  24. Chapter 15 : Cannabidiol (CBD): Abuse and physical dependence potential
  25. Chapter 16 : 4,5-Dihydro-1H-pyrazole/3,4-Diarylpyrazoline class of cannabinoid-1 (CB1R) receptor antagonists and their potential in medicinal applications
  26. Chapter 17 : Neurobiology of the endocannabinoid system and relevance to cannabis use
  27. Chapter 18 : Neurobiology of the kynurenine pathway and cannabis misuse: A new narrative
  28. Chapter 19 : Central nervous system cancers and use of cannabis and related products: An updated narrative
  29. Chapter 20 : The relationship between glutamate and resting-state connectivity in chronic cannabis users
  30. Chapter 21 : Brain metabolic responses to cannabis use in people with multiple sclerosis: Insights from [18F]-FDG positron emission tomography and functional MRI
  31. Chapter 22 : Genetic variation and acute responses to cannabis
  32. Chapter 23 : Cell signaling of the CB1 cannabinoid receptor via β-arrestins, cannabinoid receptor interacting protein (CRIP1a) and other regulatory proteins
  33. Chapter 24 : Impact of cannabis on memory: From in utero to adulthood
  34. Chapter 25 : Age-related considerations in the use of cannabinoids: Focus on drug interactions, physiology, and drug effects
  35. Chapter 26 : Cannabis, binge drinking, and memory in adolescents and young adults
  36. Chapter 27 : The role of ΔFosB in the plasticity of the cannabinoid system
  37. Chapter 28 : Functional profile of synthetic cannabinoid receptor agonists: Exploring cannabinoid and noncannabinoid targets
  38. Chapter 29 : Linking the G-protein-coupled receptor 55 (GPR55) to the cannabinoid receptors (CB1 and CB2): A new narrative
  39. Chapter 30 : Proteomic analysis of cannabinoids in human oligodendrocyte cells
  40. Chapter 31 : Cannabinoids and endocannabinoid signaling at the basal forebrain cholinergic system
  41. Chapter 32 : Cannabidiol (the major nonpsychotropic cannabinoid in the cannabis plant) and the PI3K/AKT signaling pathway in the CNS
  42. Chapter 33 : Effects of cannabidiol and other phytocannabinoids on voltage- and ligand-gated ion channels
  43. Chapter 34 : Cannabis, neurodevelopment, and the “two-hit” hypothesis
  44. Chapter 35 : Impact of Δ9-tetrahydrocannabinol (THC) and synthetic “spice” cannabinoids on nicotine use and abuse
  45. Chapter 36 : Synthetic cannabinoid receptor agonists compared to Δ9-tetrahydrocannabinol: Neurological effects and beyond
  46. Chapter 37 : The DSM: 5 Criteria of cannabis use disorder: Methods and applications
  47. Chapter 38 : Cannabis and clinical high risk for psychosis: Monitoring and smartphones
  48. Chapter 39 : The impact of cannabis and cannabinoids on the skin
  49. Chapter 40 : Cannabis consumption in reproductive function and teratogenicity
  50. Chapter 41 : Phytocannabinoids have cytotoxic, antiproliferative, and antimigratory activities on cancer cells and cancer stem cells
  51. Chapter 42 : Motivational interviewing for cannabis use disorders: A narrative review from research to practice
  52. Chapter 43 : An overview of current pharmacologic interventions for management of cannabis withdrawal syndrome and the evidence for their use
  53. Chapter 44 : Managing cannabinoid hyperemesis syndrome in pediatrics: A new narrative review
  54. Chapter 45 : Gabapentinoids for the treatment of cannabis use disorder: A focus on human laboratory research
  55. Chapter 46 : Treating psychosis in users of synthetic cannabinoids
  56. Chapter 47 : Recommended resources for studying and investigating cannabis use, neurobiology, psychology, and treatments
  57. Index
  58. A